EUTM file information

018693083

ONMOVY


April 27, 2022

Trademark Summary

The trademark ONMOVY was filed by GrĂ¼nenthal GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on May 3, 2022, and received one opposition filed on July 31, 2022 by Eli Lilly and Company on Likelihood of confusion. the opponent was represented by PAGE, WHITE & FARRER GERMANY LLP and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 31, 2022

The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).

The Appeal with reference B R2402/2023-5 was Trade mark application allowed according to Article 8(1)(b) EUTMR with decision issued on September 26, 2024 by the EUIPO. The Opposition with reference B 003175703 was rejected according to Article 8(1)(b) EUTMR with decision issued on November 28, 2023 by the EUIPO.


Goods And Services

  • The mark was filed in class 5 with Pharmaceuticals namely pharmaceutical preparations for the treatment of osteoarthritis, rheumatoid arthritis, diabetic neuropathy, peripheral neuropathy, small fibre neuropathy, trigeminal neuralgia, post herpetic neuralgia, post amputation neuropathic pain, post operative pain, cancer-related pain, trigger point pain, sciatica, overactive bladder syndrome, fibromyalgia syndrome, erythromelalgia.